Biomedical Engineering Reference
In-Depth Information
angiogenesis in infarcted heart tissue,
Circulation
,
104
, pp. 2063-
2068.
5. Kellar, R.S., et al. (2005). Cardiac patch constructed from human
fibroblasts attenuates reduction in cardiac function after acute infarct,
Tissue Eng
, pp. 1678-1687.
6. Thai, H.M., et al. (2009). Implantation of a three-dimensional fibroblast
matrix improves left ventricular function and blood flow after acute
myocardial infarction,
.,
11
, pp. 283-295.
7. Lancaster, J., et al. (2010). Viable fibroblast matrix patch induces
angiogenesis and increases myocardial blood flow in heart failure after
myocardial infarction,
Cell Transplant.
,
18
, pp. 3065-3073.
8. Fitzpatrick III, J.R., et al. (2010). Tissue-engineered pro-angiogenic
fibroblast scaffold improves myocardial perfusion and function and
limits ventricular remodeling after infarction,
Tissue Eng. A
,
16
J. Thorac. Cardiovasc.
, pp. 667-676.
9. Kellar, R.S., et al. (2011). Three-dimensional fibroblast cultures
stimulate improved ventricular performance in chronically ischemic
canine hearts,
Surg.
,
140
Tissue Eng. A
,
17
, pp. 2177-2186.
, last modified July 1,
2012, http://www.theregen.com/technoclinical.html.
11. Piao, H., et al. (2007). Effects of cardiac patches engineered with
bone marrow-derived mononuclear cells and PGCL scaffolds in a rat
myocardial infarction model,
10.
Theregen, Inc.: Anginere Clinical Development
, pp. 641-649.
12. Jin, J., et al. (2009). Transplantation of mesenchymal stem cells within
a poly(lactide-co-ε-caprolactone) scaffold improves cardiac function
in a rat myocardial infarction model,
Biomaterials
,
28
Eur. J. Heart Fail.
,
11
, pp. 147-
153.
13. Ozawa, T., et al. (2002). Optimal biomaterial for creation of autologous
cardiac grafts,
(12 Suppl 1), pp. I176-I182.
14. Ozawa, T., et al. (2004). Tissue-engineered grafts matured in the right
ventricular outflow tract,
Circulation
,
106
, pp. 169-177.
15. Matsubayashi, K., et al. (2003). Improved left ventricular aneurysm
repair with bioengineered vascular smooth muscle grafts,
Cell Transplant
.,
13
Circulation
,
(Suppl 1), pp. II219-II225.
16. Siepe, M., et al. (2006). Myoblast-seeded biodegradable scaffolds to
prevent post-myocardial infarction evolution toward heart failure,
108
J
Thorac. Cardiovasc. Surg.,
132
, pp. 124-131.
